Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Giner

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Medicina Clinica|November 15, 2001
[Renin-angiotensin system genetic polymorphisms and essential hypertension in the Spanish population]V Giner, D Corella, F J Chaves, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working PartyJ P Sculier, J Klastersky, V Giner, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2003
Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancerI Maestu, L Gómez-Aldaraví, M D Torregrosa, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, P Libert, et al.
Seminars in Oncology|February 1, 1995
Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the European Lung Cancer Working PartyJ P Sculier, G Bureau, V Giner, et al.
AIDS (London, England)|August 16, 2001
Lymphoid tissue viral burden and duration of viral suppression in plasmaE Martínez, M Arnedo, V Giner, et al.
Lung Cancer (Amsterdam, Netherlands)|June 19, 2012
Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working PartyT Berghmans, J J Lafitte, V Giner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, G Bureau, et al.
The European Respiratory Journal|May 31, 2011
Validation and comparison of several published prognostic systems for patients with small cell lung cancerM Paesmans, J J Lafitte, J Lecomte, et al.
Lung Cancer (Amsterdam, Netherlands)|September 23, 2008
A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancerT Berghmans, P Van Houtte, M Paesmans, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Medicina Clinica|November 15, 2001
[Renin-angiotensin system genetic polymorphisms and essential hypertension in the Spanish population]V Giner, D Corella, F J Chaves, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working PartyJ P Sculier, J Klastersky, V Giner, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2003
Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancerI Maestu, L Gómez-Aldaraví, M D Torregrosa, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, P Libert, et al.
Seminars in Oncology|February 1, 1995
Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the European Lung Cancer Working PartyJ P Sculier, G Bureau, V Giner, et al.
AIDS (London, England)|August 16, 2001
Lymphoid tissue viral burden and duration of viral suppression in plasmaE Martínez, M Arnedo, V Giner, et al.
Lung Cancer (Amsterdam, Netherlands)|June 19, 2012
Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working PartyT Berghmans, J J Lafitte, V Giner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, G Bureau, et al.
The European Respiratory Journal|May 31, 2011
Validation and comparison of several published prognostic systems for patients with small cell lung cancerM Paesmans, J J Lafitte, J Lecomte, et al.
Lung Cancer (Amsterdam, Netherlands)|September 23, 2008
A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancerT Berghmans, P Van Houtte, M Paesmans, et al.
Pageof 8